Cargando…
MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B
Docetaxel is one of the most commonly used drugs in prostate cancer (PCa) chemotherapy, but its therapeutic effect in PCa is usually limited due to its drug resistance. APOBEC3B is a DNA cytosine deaminase that can alter biological processes, including chemoresistance. APOBEC3B is upregulated in var...
Autores principales: | Liu, Lina, Zhang, Yan, Hu, Xi, Zhang, Hui, Jiang, Chenyang, Guo, Yan, Cang, Shundong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302536/ https://www.ncbi.nlm.nih.gov/pubmed/37364333 http://dx.doi.org/10.1016/j.tranon.2023.101723 |
Ejemplares similares
-
MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK
por: Zhang, Wei, et al.
Publicado: (2020) -
miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
por: Zhang, Dapeng, et al.
Publicado: (2020) -
Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p
por: Faure-Dupuy, Suzanne, et al.
Publicado: (2021) -
miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells
por: Yang, Rong, et al.
Publicado: (2016) -
Expression of miR-21 and miR-138 in colon cancer and its effect on cell proliferation and prognosis
por: You, Changxuan, et al.
Publicado: (2019)